Yan Yang

5.9k total citations · 2 hit papers
141 papers, 3.6k citations indexed

About

Yan Yang is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yan Yang has authored 141 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 37 papers in Oncology and 33 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yan Yang's work include Cancer-related molecular mechanisms research (11 papers), Connexins and lens biology (8 papers) and RNA modifications and cancer (8 papers). Yan Yang is often cited by papers focused on Cancer-related molecular mechanisms research (11 papers), Connexins and lens biology (8 papers) and RNA modifications and cancer (8 papers). Yan Yang collaborates with scholars based in China, United States and United Kingdom. Yan Yang's co-authors include Lucia Schuger, Qiong Wu, Karl Herrup, Hong‐Bing Shu, Shukui Qin, Yan‐Yi Wang, Xiao‐Lian Zhang, Cao‐Qi Lei, Bo Zhong and Aiping Mao and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Yan Yang

126 papers receiving 3.6k citations

Hit Papers

Astroglial Kir4.1 in the lateral habenula drives neur... 2013 2026 2017 2021 2018 2013 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Astroglial Kir4.1 in the lateral habenula drives neuronal bursts in depression
    2018 437 citations Yan Yang et al. profile →
  2. Apatinib for Chemotherapy-Refractory Advanced Metastatic Gastric Cancer: Results From a Randomized, Placebo-Controlled, Parallel-Arm, Phase II Trial
    2013 417 citations Yan Yang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yan Yang China 31 1.6k 691 670 667 654 141 3.6k
Qi Mei China 30 1.4k 0.8× 803 1.2× 495 0.7× 433 0.6× 473 0.7× 139 3.3k
Emilio Ciusani Italy 36 2.1k 1.3× 1.0k 1.5× 610 0.9× 348 0.5× 953 1.5× 152 4.7k
Mikhail G. Dozmorov United States 36 2.2k 1.3× 567 0.8× 722 1.1× 363 0.5× 708 1.1× 153 4.0k
Roberto Tamma Italy 34 1.8k 1.1× 971 1.4× 624 0.9× 483 0.7× 798 1.2× 124 3.8k
Rong Mao United States 35 1.8k 1.1× 469 0.7× 297 0.4× 785 1.2× 550 0.8× 135 4.8k
Michael Cox Canada 38 2.4k 1.5× 992 1.4× 321 0.5× 1.3k 2.0× 874 1.3× 107 4.7k
Enrique Zudaire United States 29 1.7k 1.0× 905 1.3× 494 0.7× 341 0.5× 404 0.6× 72 3.6k
Megan R. Lerner United States 32 2.0k 1.2× 694 1.0× 388 0.6× 299 0.4× 1.2k 1.8× 124 4.0k
Hajime Hosoi Japan 35 3.1k 1.9× 981 1.4× 406 0.6× 835 1.3× 803 1.2× 189 5.1k
József Dudás Austria 37 1.8k 1.1× 990 1.4× 418 0.6× 428 0.6× 971 1.5× 138 4.1k

Countries citing papers authored by Yan Yang

Since Specialization
Citations

This map shows the geographic impact of Yan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Yang more than expected).

Fields of papers citing papers by Yan Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Yang. The network helps show where Yan Yang may publish in the future.

Co-authorship network of co-authors of Yan Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Yang. A scholar is included among the top collaborators of Yan Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Yang. Yan Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Yan, Guanxiang Liang, Zhixuan Chen, et al.. (2025). Atractylenolide-Ⅲ binds non-structural protein-1 to suppress influenza A by modulating macrophage polarization and alternative polyadenylation. Phytomedicine. 141. 156704–156704. 1 indexed citations
2.
Li, Shanshan, Fenghua Wang, Dongxu Liu, et al.. (2025). Mycobacterium tuberculosis infection may increase the degrees of malignancy in lung adenocarcinoma. Frontiers in Immunology. 16. 1537520–1537520. 1 indexed citations
3.
4.
Wang, Wei, et al.. (2025). LCLAT1 as a Potential Biomarker for Predicting Clinical Prognosis, Tumor Immunity, and Therapeutic Efficacy in Hepatocellular Carcinoma. The FASEB Journal. 39(10). e70625–e70625. 1 indexed citations
5.
6.
Yang, Yan, et al.. (2025). Association between hemoglobin glycation index and poor outcome after endovascular thrombectomy in acute ischemic stroke. Frontiers in Aging Neuroscience. 17. 1533584–1533584.
7.
8.
Yang, Yan, et al.. (2024). Safety and efficacy of remimazolam in mechanical ventilation in the ICU: a protocol for systematic evaluation and meta-analysis. BMJ Open. 14(12). e091172–e091172. 1 indexed citations
9.
Yang, Yan, Junjun Wang, Hanqi Yang, et al.. (2023). Development and validation of novel immune-inflammation-based clinical predictive nomograms in HER2-negative advanced gastric cancer. Frontiers in Oncology. 13. 1185240–1185240.
10.
Xiao, Han, et al.. (2022). Liquiritin Protects Against Cardiac Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway. SHILAP Revista de lepidopterología.
11.
Chen, Jin, Rui Li, Tuo Deng, et al.. (2021). Identification and Validation of a Prognostic Prediction Model of m6A Regulator-Related LncRNAs in Hepatocellular Carcinoma. Frontiers in Molecular Biosciences. 8. 784553–784553. 10 indexed citations
12.
13.
Nie, Ying, Yan Yang, Yong Ran, et al.. (2020). Ubiquitination of TLR3 by TRIM3 signals its ESCRT-mediated trafficking to the endolysosomes for innate antiviral response. Proceedings of the National Academy of Sciences. 117(38). 23707–23716. 30 indexed citations
14.
Yang, Yan, Min Gao, Ri‐Ning Tang, et al.. (2020). Association Between the Serum Uric Acid Level and the Severity of Coronary Artery Disease in a Retrospective Study of China Nondialysis CKD Patients. Metabolic Syndrome and Related Disorders. 18(4). 206–211. 6 indexed citations
15.
Zhu, Yue, et al.. (2020). Clinical and molecular characteristics of secondary breast metastases from primary lung cancer: a study of 22 Chinese cases.. PubMed Central. 13(7). 1880–1885. 2 indexed citations
16.
Shi, Jiaqi, Yan Yang, Yang Zhao, et al.. (2019). EGFR mutations are significantly associated with visceral pleural invasion development in non-small-cell lung cancer patients. SHILAP Revista de lepidopterología. 1 indexed citations
17.
Li, Jie, Bo Zhang, Yan Yang, Jian Jin, & Yong Liu. (2018). Aldehyde dehydrogenase 1 as a predictor of the neoadjuvant chemotherapy response in breast cancer. Medicine. 97(34). e12056–e12056. 11 indexed citations
18.
Zhang, Na, Haibo Yu, Qin Zhang, et al.. (2017). CXCR7/CXCL12 axis is involved in lymph node and liver metastasis of gastric carcinoma. World Journal of Gastroenterology. 23(17). 3053–3053. 20 indexed citations
19.
Liu, Jun, et al.. (2012). [Significance of TIMP-1 and nm-23 expressions in HER-2-positive breast cancer].. PubMed. 34(8). 600–4. 2 indexed citations
20.
Zheng, Junhua, et al.. (2010). Laparoscopic radical nephrectomy for clinical stage T_2 renal cell carcinoma patients. Zhonghua miniao waike zazhi. 31(3). 157–160. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qi Mei Breakdown of academic impact, for papers by Emilio Ciusani Breakdown of academic impact, for papers by Mikhail G. Dozmorov Breakdown of academic impact, for papers by Roberto Tamma Breakdown of academic impact, for papers by Rong Mao Breakdown of academic impact, for papers by Michael Cox Breakdown of academic impact, for papers by Enrique Zudaire Breakdown of academic impact, for papers by Megan R. Lerner Breakdown of academic impact, for papers by Hajime Hosoi Breakdown of academic impact, for papers by József Dudás
Rankless by CCL
2026